7 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18867764 | USE OF ENGINEERED JURONA VIRUS (JURV) AS AN ONCOLYTIC VIRUS PLATFORM FOR HUMAN CANCERS | ABBOTT, KODYE LEE | 1634 | Non-Final OA | Nov 20, 2024 |
| 18019052 | CST6, CELLS EXPRESSING CST6 AND METHODS OF USE | XIE, XIAOZHEN | 1674 | Non-Final OA | Jan 31, 2023 |
| 18078924 | DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY | SCHUBERG, LAURA J | 1631 | Non-Final OA | Dec 10, 2022 |
| 17799638 | NOVEL TDZD ANALOGS AS AGENTS THAT DELAY, PREVENT, OR REVERSE AGE-ASSOCIATED DISEASES AND AS ANTI-CANCER AND ANTILEUKEMIC AGENTS | RAO, PADMAJA S | 1627 | Non-Final OA | Aug 12, 2022 |
| 17769663 | BIOLOGICALLY SYNTHESIZED HYDROXYAPATITE FOR BONE REGENERATION AND TISSUE ENGINEERING | NGUYEN, NGHI V | 1653 | Non-Final OA | Apr 15, 2022 |
| 17767784 | USE OF SIMULTANEOUS MARKER DETECTION FOR ASSESSING DIFUSE GLIOMA AND RESPONSIVENESS TO TREATMENT | SCHLOOP, ALLISON ELIZABETH | 1683 | Non-Final OA | Apr 08, 2022 |
| 17766498 | PIEZO1 AGONISTS FOR THE PROMOTION OF BONE FORMATION | SCHMIDT, IZABELA MARIA | 1621 | Non-Final OA | Apr 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial